Latest Sense Stories
Most patients who have a reduced ability to smell or detect odors seem to attach less importance to the sense of smell in their daily lives than people with a normal olfactory function.
BELLEVUE, Wash., April 12, 2011 /PRNewswire/ -- HTC Corp., a global leader in mobile innovation and design, today introduced the HTC Sensation 4G, a smartphone that shines a spotlight on entertainment with HTC's new HTC Watch(TM) video service.
CARLSBAD, Calif., April 11, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast: Recent Advances in Isis' Development What: Pipeline Wednesday, April 13, 2011 at 12:00 When: p.m. ET /9:00 a.m.
Following years of futile attempts, new research from the Monell Center demonstrates that living human taste cells can be maintained in culture for at least seven months.
CARLSBAD, Calif., March 30, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Needham's 10th Annual Healthcare Conference on Wednesday, April 06, 2011 at 10:40 a.m.
Researchers seeking to unravel the most ancient yet least understood of the five senses â€“ smell â€“ have discovered a previously unknown step in how odors are detected and processed by the brain.
ORLANDO, Fla., March 22, 2011 /PRNewswire/ -- International CTIA Wireless 2011 -- HTC Corporation, a global leader in smartphone innovation and design, will be highlighting its latest devices and technologies at International CTIA Wireless 2011 in Orlando, Fla.
MANHATTAN BEACH, Calif., March 16, 2011 /PRNewswire/ -- With warm weather and bathing suit season just around the corner, the SENSAÂ® Weight-Loss System, a revolutionary six-month weight-loss program developed by neurologist and smell and taste expert Dr.
New research says that people who make a high-class living smelling perfumes and wines are not born with an exceptional sense of smell but acquire it with many years of sniffing.
CARLSBAD, Calif., March 7, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Roth's 23rd Annual OC Growth Stock Conference on Monday, March 14, 2011 at 1:00 p.m.
- A trick or prank.
More Images (2 images) »